Gabelli Healthcare & WellnessRx Trust
GRX
$9.28
$0.080.87%
| Weiss Ratings | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Gabelli | |||
| Manager/Tenure (Years) | Mario J. Gabelli (18), Kevin V. Dreyer (15), Jennie Tsai (5), 2 others | |||
| Website | http://www.gabelli.com | |||
| Fund Information | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Gabelli Healthcare & WellnessRx Trust | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 19, 2007 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.27% | |||
| Dividend | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.50% | |||
| Asset Allocation | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 29.61% | |||
| Stock | 62.47% | |||
| U.S. Stock | 50.81% | |||
| Non-U.S. Stock | 11.66% | |||
| Bond | 7.92% | |||
| U.S. Bond | 7.92% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.34% | |||
| 30-Day Total Return | -5.34% | |||
| 60-Day Total Return | -2.32% | |||
| 90-Day Total Return | -1.67% | |||
| Year to Date Total Return | -1.67% | |||
| 1-Year Total Return | -3.96% | |||
| 2-Year Total Return | -5.01% | |||
| 3-Year Total Return | 0.58% | |||
| 5-Year Total Return | -6.01% | |||
| Price | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $8.95 | |||
| 1-Month High Price | $9.96 | |||
| 52-Week Low Price | $8.95 | |||
| 52-Week Low Price (Date) | Mar 30, 2026 | |||
| 52-Week High Price | $9.99 | |||
| 52-Week High Price (Date) | Apr 02, 2025 | |||
| NAV | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $10.10 | |||
| 1-Month Low NAV | $9.82 | |||
| 1-Month High NAV | $10.96 | |||
| 52-Week Low NAV | $9.82 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $11.34 | |||
| 52-Week High Price (Date) | Apr 02, 2025 | |||
| Beta / Standard Deviation | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.08 | |||
| Standard Deviation | 17.45 | |||
| Balance Sheet | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 151.26M | |||
| Operating Ratios | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.99% | |||
| Turnover Ratio | 23.00% | |||
| Performance | GRX-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.72% | |||
| Last Bear Market Total Return | -13.73% | |||